These factors affected the prostatic cancer cell phenotype, inducing an epithelial-to-mesenchymal transition (EMT), cancer cell proliferation, invasion and resistance to chemotherapy, as well as increasing PD-L1 expression promoting tumor immune evasion71–73. The gene discussed is CD274; the disease is neoplasm.